-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Adaption of Next Generation Sequencing, Next Generation Flow Cytometry, and CyTOF: Diverse Ways of Detection

PhD Trainee
Program: Scientific Workshops @ ASH
Thursday, December 3, 2020: 8:32 AM-9:12 AM
Moderator:
Disclosures:
Hillengass: Adaptive, Amgen, BMS, Celgene, GSK, Janssen, Oncopeptides, Oncotracker, Takeda: Honoraria.
Flow Cytometric Measurement Issues for MRD and IP in Multiple Myeloma

Bruno Paiva, PhD

University of Navarra, Pamplona, Navarra, Spain
Mass Spectrometry vs. MRD

David M Foureau, PhD

Immune Monitoring Core Laboratory, Levine Cancer Institute, Atrium Health, Charlotte, NC
Genetics and MRD

Martin F. Kaiser, MD, FRCP, FRCPath

The Institute of Cancer Research, London, United Kingdom; The Royal Marsden NHS Foundation Trust, London, United Kingdom
Single Cell Immune Profiling in Multiple Myeloma

Nizar Bahlis, MD

University of Calgary, Calgary, AB, Canada
Panel Discussion & Live Q&A
See more of: Scientific Workshops @ ASH
<< Previous Session | Next Session >>